PET for radiation treatment planning of brain tumours

Anca L. Grosu, Wolfgang A. Weber

Research output: Contribution to journalReview articlepeer-review

101 Scopus citations

Abstract

AA-PET (MET-PET and FET-PET) can be used for gross tumour volume (GTV) delineation in brain gliomas and for the differentiation between treatment-related changes (pseudo-progression, pseudo-regression) and residual/recurrent tumour. There are some data showing that MET-PET and (DOTATOC)-PET can be used for GTV delineation in meningiomas and glomus tumours. The role of PET in the visualization of the biological characteristics of the tumours: proliferation (FLT-PET), hypoxia (FMISO-PET) and angiogenesis/peptide expression (RGD-PET) should be investigated in future studies.

Original languageEnglish
Pages (from-to)325-327
Number of pages3
JournalRadiotherapy and Oncology
Volume96
Issue number3
DOIs
StatePublished - Sep 2010
Externally publishedYes

Keywords

  • Brain tumours
  • PET
  • Radiation treatment planning

Fingerprint

Dive into the research topics of 'PET for radiation treatment planning of brain tumours'. Together they form a unique fingerprint.

Cite this